1. Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. (14th October 2021) Authors: Oyama, K; Raz, I; Cahn, A; Goodrich, E; Bhatt, D; Leiter, L; McGuire, D; Wilding, J; Gause-Nilsson, I; Mosenzon, O; Sabatine, M; Wiviott, S Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S138 Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole. (2nd December 2011) Authors: Shulgina, L; Cahn, A; Chilvers, E; Parfrey, H; Clark, A; Wilson, E; Twentyman, O; Davison, T; Curtin, J; Wilson, A Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Issue 7 (1st February 2008) Authors: Singh, D; Brooks, J; Hagan, G; Cahn, A; O'Connor, B J Journal: Thorax Issue: Volume 63:Issue 7(2008) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗